001     273921
005     20241208000109.0
024 7 _ |a 10.1126/scitranslmed.adl4616
|2 doi
024 7 _ |a pmid:39630885
|2 pmid
024 7 _ |a 1946-6234
|2 ISSN
024 7 _ |a 1946-6242
|2 ISSN
024 7 _ |a altmetric:171578268
|2 altmetric
037 _ _ |a DZNE-2024-01395
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Dinkel, Lina
|0 P:(DE-2719)2813128
|b 0
|e First author
245 _ _ |a Myeloid cell-specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease.
260 _ _ |a Washington, DC
|c 2024
|b AAAS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1733491094_24063
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Niemann-Pick type C (NPC) disease is an inherited lysosomal storage disorder mainly driven by mutations in the NPC1 gene, causing lipid accumulation within late endosomes/lysosomes and resulting in progressive neurodegeneration. Although microglial activation precedes neuronal loss, it remains elusive whether loss of the membrane protein NPC1 in microglia actively contributes to NPC pathology. In a mouse model with depletion of NPC1 in myeloid cells, we report severe alterations in microglial lipidomic profiles, including the enrichment of bis(monoacylglycero)phosphate, increased cholesterol, and a decrease in cholesteryl esters. Lipid dyshomeostasis was associated with microglial hyperactivity, marked by an increase in translocator protein 18 kDa (TSPO). These hyperactive microglia initiated a pathological cascade resembling NPC-like phenotypes, including a shortened life span, motor impairments, astrogliosis, neuroaxonal pathology, and increased neurofilament light chain (NF-L), a neuronal injury biomarker. As observed in the mouse model, patients with NPC showed increased NF-L in the blood and microglial hyperactivity, as visualized by TSPO-PET imaging. Reduced TSPO expression in blood-derived macrophages of patients with NPC was measured after N-acetyl-l-leucine treatment, which has been recently shown to have beneficial effects in patients with NPC, suggesting that TSPO is a potential marker to monitor therapeutic interventions for NPC. Conclusively, these results demonstrate that myeloid dysfunction, driven by the loss of NPC1, contributes to NPC disease and should be further investigated for therapeutic targeting and disease monitoring.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Niemann-Pick C1 Protein
|2 NLM Chemicals
650 _ 7 |a Intracellular Signaling Peptides and Proteins
|2 NLM Chemicals
650 _ 7 |a Npc1 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Bzrp protein, mouse
|2 NLM Chemicals
650 _ 7 |a Receptors, GABA
|2 NLM Chemicals
650 _ 7 |a NPC1 protein, human
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Niemann-Pick Disease, Type C: pathology
|2 MeSH
650 _ 2 |a Niemann-Pick Disease, Type C: metabolism
|2 MeSH
650 _ 2 |a Niemann-Pick C1 Protein
|2 MeSH
650 _ 2 |a Intracellular Signaling Peptides and Proteins: metabolism
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Microglia: metabolism
|2 MeSH
650 _ 2 |a Microglia: pathology
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Myeloid Cells: metabolism
|2 MeSH
650 _ 2 |a Myeloid Cells: pathology
|2 MeSH
650 _ 2 |a Receptors, GABA: metabolism
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Gliosis: pathology
|2 MeSH
650 _ 2 |a Gliosis: metabolism
|2 MeSH
700 1 _ |a Hummel, Selina
|0 P:(DE-2719)9002483
|b 1
700 1 _ |a Zenatti, Valerio
|0 P:(DE-2719)9002392
|b 2
700 1 _ |a Malara, Mariagiovanna
|0 P:(DE-2719)9002458
|b 3
700 1 _ |a Tillmann, Yannik
|0 P:(DE-2719)9002700
|b 4
700 1 _ |a Colombo, Alessio Vittorio
|0 P:(DE-2719)2340744
|b 5
700 1 _ |a Sebastian Monasor, Laura
|0 P:(DE-2719)2812269
|b 6
700 1 _ |a Suh, Jung H
|0 0000-0001-8119-326X
|b 7
700 1 _ |a Logan, Todd
|0 0000-0003-2081-782X
|b 8
700 1 _ |a Roth, Stefan
|0 0000-0001-6823-2981
|b 9
700 1 _ |a Paeger, Lars
|0 P:(DE-2719)9002242
|b 10
700 1 _ |a Hoffelner, Patricia
|0 0009-0009-9728-8162
|b 11
700 1 _ |a Bludau, Oliver
|0 0009-0005-9426-0325
|b 12
700 1 _ |a Schmidt, Andree
|0 P:(DE-2719)2812225
|b 13
700 1 _ |a Müller, Stephan A
|0 P:(DE-2719)2810938
|b 14
700 1 _ |a Schifferer, Martina
|0 P:(DE-2719)2812260
|b 15
700 1 _ |a Nuscher, Brigitte
|0 P:(DE-2719)9000236
|b 16
700 1 _ |a Njavro, Jasenka Rudan
|0 P:(DE-2719)2811277
|b 17
700 1 _ |a Prestel, Matthias
|0 P:(DE-2719)9001400
|b 18
700 1 _ |a Bartos, Laura M
|0 0009-0007-6158-319X
|b 19
700 1 _ |a Wind-Mark, Karin
|0 P:(DE-2719)9001653
|b 20
700 1 _ |a Slemann, Luna
|b 21
700 1 _ |a Hoermann, Leonie
|0 0009-0006-9074-3474
|b 22
700 1 _ |a Kunte, Sebastian T
|0 0009-0007-3543-5329
|b 23
700 1 _ |a Gnoerich, Johannes
|0 P:(DE-2719)9001652
|b 24
700 1 _ |a Lindner, Simon
|0 0009-0007-4379-4436
|b 25
700 1 _ |a Simons, Mikael
|0 P:(DE-2719)2811642
|b 26
700 1 _ |a Herms, Jochen
|0 P:(DE-2719)2810441
|b 27
700 1 _ |a Paquet, Dominik
|0 P:(DE-2719)2010112
|b 28
700 1 _ |a Lichtenthaler, Stefan F
|0 P:(DE-2719)2181459
|b 29
700 1 _ |a Bartenstein, Peter
|0 0009-0005-0734-4994
|b 30
700 1 _ |a Franzmeier, Nicolai
|0 0000-0001-9736-2283
|b 31
700 1 _ |a Liesz, Arthur
|0 0000-0002-9069-2594
|b 32
700 1 _ |a Grosche, Antje
|0 0000-0003-0338-7530
|b 33
700 1 _ |a Bremova-Ertl, Tatiana
|0 0000-0002-7397-045X
|b 34
700 1 _ |a Catarino, Claudia
|0 0000-0002-6528-7570
|b 35
700 1 _ |a Beblo, Skadi
|b 36
700 1 _ |a Bergner, Caroline
|b 37
700 1 _ |a Schneider, Susanne A
|b 38
700 1 _ |a Strupp, Michael
|0 0000-0002-9544-2279
|b 39
700 1 _ |a Di Paolo, Gilbert
|0 0000-0003-1032-1265
|b 40
700 1 _ |a Brendel, Matthias
|0 P:(DE-2719)9001539
|b 41
700 1 _ |a Tahirovic, Sabina
|0 P:(DE-2719)2442036
|b 42
|e Last author
773 _ _ |a 10.1126/scitranslmed.adl4616
|g Vol. 16, no. 776, p. eadl4616
|0 PERI:(DE-600)2518839-2
|n 776
|p eadl4616
|t Science translational medicine
|v 16
|y 2024
|x 1946-6234
856 4 _ |u https://pub.dzne.de/record/273921/files/DZNE-2024-01395_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/273921/files/DZNE-2024-01395_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:273921
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2813128
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 1
|6 P:(DE-2719)9002483
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002392
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9002458
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)9002700
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2340744
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2812269
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)9002242
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)2812225
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2810938
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2812260
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2811277
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)9001400
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)9001653
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 24
|6 P:(DE-2719)9001652
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2811642
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2810441
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 29
|6 P:(DE-2719)2181459
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 41
|6 P:(DE-2719)9001539
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 42
|6 P:(DE-2719)2442036
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 1
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI TRANSL MED : 2022
|d 2023-10-26
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b SCI TRANSL MED : 2022
|d 2023-10-26
920 1 _ |0 I:(DE-2719)1140003
|k AG Tahirovic
|l Juvenile Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1110001
|k AG Herms
|l Translational Brain Research
|x 1
920 1 _ |0 I:(DE-2719)1110006
|k AG Lichtenthaler
|l Neuroproteomics
|x 2
920 1 _ |0 I:(DE-2719)1110000-4
|k AG Misgeld
|l Neuronal Cell Biology
|x 3
920 1 _ |0 I:(DE-2719)1110007
|k AG Haass
|l Molecular Neurodegeneration
|x 4
920 1 _ |0 I:(DE-2719)1110008
|k AG Simons
|l Molecular Neurobiology
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1140003
980 _ _ |a I:(DE-2719)1110001
980 _ _ |a I:(DE-2719)1110006
980 _ _ |a I:(DE-2719)1110000-4
980 _ _ |a I:(DE-2719)1110007
980 _ _ |a I:(DE-2719)1110008
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21